Literature DB >> 20954840

Comparison of methods to detect HIV dual infection.

Mary Pacold1, Davey Smith, Susan Little, Pok Man Cheng, Parris Jordan, Caroline Ignacio, Douglas Richman, Sergei Kosakovsky Pond.   

Abstract

Current methods to detect intraclade HIV dual infection are poorly suited for determining its prevalence in large cohorts. To investigate the potential of ultra-deep sequencing to screen for dual infection, we compared it to bulk sequence-based synonymous mixture index and the current standard of single genome sequencing. The synonymous mixture index identified samples likely to harbor dual infection, while ultra-deep sequencing captured more intra-host viral diversity than single genome sequencing at approximately 40% of the cost and 20% of the laboratory and analysis time. The synonymous mixture index and ultra-deep sequencing are promising methods for rapid and cost-effective systematic identification of HIV dual infection.

Entities:  

Mesh:

Year:  2010        PMID: 20954840      PMCID: PMC3011997          DOI: 10.1089/aid.2010.0042

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   1.723


  28 in total

1.  Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers.

Authors:  Jandre Grobler; Clive M Gray; Cecilia Rademeyer; Cathal Seoighe; Gita Ramjee; Salim Abdool Karim; Lynn Morris; Carolyn Williamson
Journal:  J Infect Dis       Date:  2004-08-25       Impact factor: 5.226

2.  HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications.

Authors:  Gary P Wang; Angela Ciuffi; Jeremy Leipzig; Charles C Berry; Frederic D Bushman
Journal:  Genome Res       Date:  2007-06-01       Impact factor: 9.043

3.  Frequency of HIV type 1 dual infection and HIV diversity: analysis of low- and high-risk populations in Mbeya Region, Tanzania.

Authors:  Karl-Heinz Herbinger; Martina Gerhardt; Sucheep Piyasirisilp; Doreen Mloka; Miguel A Arroyo; Oliver Hoffmann; Leonard Maboko; Deborah L Birx; Donan Mmbando; Francine E McCutchan; Michael Hoelscher
Journal:  AIDS Res Hum Retroviruses       Date:  2006-07       Impact factor: 2.205

4.  Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control.

Authors:  Rosario Zuñiga; Aldo Lucchetti; Patricia Galvan; Shyla Sanchez; Carmen Sanchez; Ana Hernandez; Hugo Sanchez; Nicole Frahm; Caitlyn H Linde; Hannah S Hewitt; William Hildebrand; Marcus Altfeld; Todd M Allen; Bruce D Walker; Bette T Korber; Thomas Leitner; Jorge Sanchez; Christian Brander
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

5.  Examination of a second region of the HIV type 1 genome reveals additional cases of superinfection.

Authors:  Anne Piantadosi; Musa Otieno Ngayo; Bhavna Chohan; Julie Overbaugh
Journal:  AIDS Res Hum Retroviruses       Date:  2008-09       Impact factor: 2.205

6.  Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance.

Authors:  Chunlin Wang; Yumi Mitsuya; Baback Gharizadeh; Mostafa Ronaghi; Robert W Shafer
Journal:  Genome Res       Date:  2007-06-28       Impact factor: 9.043

7.  Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencing.

Authors:  John Archer; Michael S Braverman; Bruce E Taillon; Brian Desany; Ian James; P Richard Harrigan; Marilyn Lewis; David L Robertson
Journal:  AIDS       Date:  2009-06-19       Impact factor: 4.177

8.  Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo.

Authors:  Athe M N Tsibris; Bette Korber; Ramy Arnaout; Carsten Russ; Chien-Chi Lo; Thomas Leitner; Brian Gaschen; James Theiler; Roger Paredes; Zhaohui Su; Michael D Hughes; Roy M Gulick; Wayne Greaves; Eoin Coakley; Charles Flexner; Chad Nusbaum; Daniel R Kuritzkes
Journal:  PLoS One       Date:  2009-05-25       Impact factor: 3.240

9.  HIV-specific probabilistic models of protein evolution.

Authors:  David C Nickle; Laura Heath; Mark A Jensen; Peter B Gilbert; James I Mullins; Sergei L Kosakovsky Pond
Journal:  PLoS One       Date:  2007-06-06       Impact factor: 3.240

10.  DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations.

Authors:  Christian Hoffmann; Nana Minkah; Jeremy Leipzig; Gary Wang; Max Q Arens; Pablo Tebas; Frederic D Bushman
Journal:  Nucleic Acids Res       Date:  2007-06-18       Impact factor: 16.971

View more
  25 in total

1.  Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants.

Authors:  Sara Gianella; Wayne Delport; Mary E Pacold; Jason A Young; Jun Yong Choi; Susan J Little; Douglas D Richman; Sergei L Kosakovsky Pond; Davey M Smith
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity.

Authors:  Matthew M Cousins; San-San Ou; Maria J Wawer; Supriya Munshaw; David Swan; Craig A Magaret; Caroline E Mullis; David Serwadda; Stephen F Porcella; Ronald H Gray; Thomas C Quinn; Deborah Donnell; Susan H Eshleman; Andrew D Redd
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

3.  Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection.

Authors:  Antoine Chaillon; Gabriel A Wagner; N Lance Hepler; Susan J Little; Sergei L Kosakovsky Pond; Gemma Caballero; Mary E Pacold; Pham Phung; Terri Wrin; Douglas D Richman; Joel O Wertheim; Davey M Smith
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

4.  A Multiplex PCR Approach for Detecting Dual Infections and Recombinants Involving Major HIV Variants.

Authors:  Pierre Cappy; Fabienne De Oliveira; Marie Gueudin; Elodie Alessandri-Gradt; Jean-Christophe Plantier
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

5.  Identification of HIV superinfection in seroconcordant couples in Rakai, Uganda, by use of next-generation deep sequencing.

Authors:  Andrew D Redd; Aleisha Collinson-Streng; Craig Martens; Stacy Ricklefs; Caroline E Mullis; Jordyn Manucci; Aaron A R Tobian; Ethan J Selig; Oliver Laeyendecker; Nelson Sewankambo; Ronald H Gray; David Serwadda; Maria J Wawer; Stephen F Porcella; Thomas C Quinn
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

6.  HIV-TRACE (TRAnsmission Cluster Engine): a Tool for Large Scale Molecular Epidemiology of HIV-1 and Other Rapidly Evolving Pathogens.

Authors:  Sergei L Kosakovsky Pond; Steven Weaver; Andrew J Leigh Brown; Joel O Wertheim
Journal:  Mol Biol Evol       Date:  2018-07-01       Impact factor: 16.240

7.  Clinical, virologic, and immunologic correlates of HIV-1 intraclade B dual infection among men who have sex with men.

Authors:  Mary E Pacold; Sergei L Kosakovsky Pond; Gabriel A Wagner; Wayne Delport; Daniel L Bourque; Douglas D Richman; Susan J Little; Davey M Smith
Journal:  AIDS       Date:  2012-01-14       Impact factor: 4.177

8.  HIV-associated neurocognitive disorder is associated with HIV-1 dual infection.

Authors:  Gabriel A Wagner; Antoine Chaillon; Siqi Liu; Donald R Franklin; Gemma Caballero; Sergei L Kosakovsky Pond; Florin Vaida; Robert K Heaton; Scott L Letendre; Igor Grant; Douglas D Richman; Davey M Smith
Journal:  AIDS       Date:  2016-11-13       Impact factor: 4.177

9.  Deep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimen.

Authors:  Randall Fisher; Gert U van Zyl; Simon A A Travers; Sergei L Kosakovsky Pond; Susan Engelbrech; Ben Murrell; Konrad Scheffler; Davey Smith
Journal:  J Virol       Date:  2012-03-28       Impact factor: 5.103

Review 10.  Frequency and implications of HIV superinfection.

Authors:  Andrew D Redd; Thomas C Quinn; Aaron A R Tobian
Journal:  Lancet Infect Dis       Date:  2013-05-31       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.